Phreesia
About: Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Employees: 2,082
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
167% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 18
21% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 61
15% more funds holding
Funds holding: 189 [Q4 2024] → 218 (+29) [Q1 2025]
1.55% more ownership
Funds ownership: 94.27% [Q4 2024] → 95.82% (+1.55%) [Q1 2025]
4% more capital invested
Capital invested by funds: $1.38B [Q4 2024] → $1.44B (+$61M) [Q1 2025]
52% less call options, than puts
Call options by funds: $6.17M | Put options by funds: $12.7M
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Truist Securities Jailendra Singh | 35%upside $35 | Buy Maintained | 29 May 2025 |
Canaccord Genuity Richard Close | 31%upside $34 | Buy Maintained | 29 May 2025 |
Keybanc Scott Schoenhaus | 8%upside $28 | Overweight Maintained | 16 Apr 2025 |
DA Davidson Robert Simmons | 31%upside $34 | Buy Maintained | 14 Apr 2025 |
Financial journalist opinion
Based on 8 articles about PHR published over the past 30 days
